Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization
Conditions: Oral Cavity Cancer; Mouth Neoplasm; Precancerous Conditions Intervention: Drug: Sintilimab Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials